Trientine hydrochloride (BioDeep_00000829268)

   


代谢物信息卡片


TRIETHYLENETETRAMINE DIHYDROCHLORIDE

化学式: C6H20Cl2N4 (218.106494)
中文名称: 三亚乙基四胺盐酸盐
谱图信息: 最多检出来源 () 0%

分子结构信息

SMILES: C(CNCCNCCN)N.Cl.Cl
InChI: 2*1H

描述信息

C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor
D064449 - Sequestering Agents > D002614 - Chelating Agents

同义名列表

2 个代谢物同义名

TRIETHYLENETETRAMINE DIHYDROCHLORIDE; Trientine hydrochloride



数据库引用编号

6 个数据库交叉引用编号

分类词条

相关代谢途径

Reactome(0)

BioCyc(0)

PlantCyc(0)

代谢反应

0 个相关的代谢反应过程信息。

Reactome(0)

BioCyc(0)

WikiPathways(0)

Plant Reactome(0)

INOH(0)

PlantCyc(0)

COVID-19 Disease Map(0)

PathBank(0)

PharmGKB(0)

0 个相关的物种来源信息

在这里通过桑基图来展示出与当前的这个代谢物在我们的BioDeep知识库中具有相关联信息的其他代谢物。在这里进行关联的信息来源主要有:

  • PubMed: 来源于PubMed文献库中的文献信息,我们通过自然语言数据挖掘得到的在同一篇文献中被同时提及的相关代谢物列表,这个列表按照代谢物同时出现的文献数量降序排序,取前10个代谢物作为相关研究中关联性很高的代谢物集合展示在桑基图中。
  • NCBI Taxonomy: 通过文献数据挖掘,得到的代谢物物种来源信息关联。这个关联信息同样按照出现的次数降序排序,取前10个代谢物作为高关联度的代谢物集合展示在桑吉图上。
  • Chemical Taxonomy: 在物质分类上处于同一个分类集合中的其他代谢物
  • Chemical Reaction: 在化学反应过程中,存在为当前代谢物相关联的生化反应过程中的反应底物或者反应产物的关联代谢物信息。

点击图上的相关代谢物的名称,可以跳转到相关代谢物的信息页面。



文献列表

  • Ziwei Zhu, Turak Ablajan, Deng Zang, Haji Akber Aisa. Guaianolide sesquiterpenes and their activity from Artemisia mongolica. Phytochemistry. 2024 Apr; 220(?):114019. doi: 10.1016/j.phytochem.2024.114019. [PMID: 38346546]
  • Umair Khurshid, Saeed Ahmad, Hammad Saleem, Arslan Hussain LodhI, Irfan Pervaiz, Mohsin Abbas Khan, Haroon Khan, Abdulwahab AlamrI, Mukhtar AnsarI, Marcello LocatellI, Muhammad Adeel Arshad, Muhammad Asif Wazir, Juwairiya Butt, Sirajudheen Anwar. Multifaced Assessment of Antioxidant Power, Phytochemical Metabolomics, In-Vitro Biological Potential and In-Silico Studies of Neurada procumbens L.: An Important Medicinal Plant. Molecules (Basel, Switzerland). 2022 Sep; 27(18):. doi: 10.3390/molecules27185849. [PMID: 36144585]
  • Anna Reid, Christopher Miller, John Peter Farrant, Rahul Polturi, David Clark, Simon Ray, Garth Cooper, Matthias Schmitt. Copper chelation in patients with hypertrophic cardiomyopathy. Open heart. 2022 02; 9(1):. doi: 10.1136/openhrt-2021-001803. [PMID: 35169044]
  • Sanjay Kumar, Biswa Ranjan Patra, Mohammed Irtaza, Praveen Kumar Rao, Suprabhat Giri, Harish Darak, Amrit Gopan, Aditya Kale, Akash Shukla. Adverse Events with D-penicillamine Therapy in Hepatic Wilson's Disease: A Single-Center Retrospective Audit. Clinical drug investigation. 2022 Feb; 42(2):177-184. doi: 10.1007/s40261-022-01117-x. [PMID: 35102516]
  • Karl Heinz Weiss, Catherine Thompson, Peter Dogterom, Yi-Jin Chiou, Tim Morley, Brinley Jackson, Naseem Amin, Camille Omar Farouk Kamlin. Comparison of the Pharmacokinetic Profiles of Trientine Tetrahydrochloride and Trientine Dihydrochloride in Healthy Subjects. European journal of drug metabolism and pharmacokinetics. 2021 Sep; 46(5):665-675. doi: 10.1007/s13318-021-00704-1. [PMID: 34357516]
  • Vitaly D Samuilov, Dmitry B Kiselevsky, Elena V Dzyubinskaya, Olga Yu Frolova. Effects of Superoxide Dismutase Inhibitors and Glucose on Cell Death and Generation of Reactive Oxygen Species in Pea Leaves. Biochemistry. Biokhimiia. 2021 Jul; 86(7):878-886. doi: 10.1134/s0006297921070087. [PMID: 34284711]
  • Francesca Castoldi, Mervi T Hyvönen, Sylvère Durand, Fanny Aprahamian, Allan Sauvat, Shoaib A Malik, Elisa Elena Baracco, Erika Vacchelli, Paule Opolon, Nicolas Signolle, Déborah Lefevre, Noelie Bossut, Tobias Eisenberg, Christopher Dammbrueck, Tobias Pendl, Margerie Kremer, Sylvie Lachkar, Claudia Einer, Bernhard Michalke, Hans Zischka, Frank Madeo, Tuomo A Keinänen, Maria Chiara Maiuri, Federico Pietrocola, Guido Kroemer. Chemical activation of SAT1 corrects diet-induced metabolic syndrome. Cell death and differentiation. 2020 10; 27(10):2904-2920. doi: 10.1038/s41418-020-0550-z. [PMID: 32376874]
  • Marcia Leung, Jaimie Wu Lanzafame, Valentina Medici. Switching Pharmacological Treatment in Wilson Disease: Case Report and Recommendations. Journal of investigative medicine high impact case reports. 2020 Jan; 8(?):2324709619896876. doi: 10.1177/2324709619896876. [PMID: 31920114]
  • Lidong Wang, Shanshan Liu, Rujie Wang, Qiangwei Li, Shihan Zhang. Regulating Phase Separation Behavior of a DEEA-TETA Biphasic Solvent Using Sulfolane for Energy-Saving CO2 Capture. Environmental science & technology. 2019 Nov; 53(21):12873-12881. doi: 10.1021/acs.est.9b02787. [PMID: 31446756]
  • Norikazu Shimizu. [Diagnosis and treatment of Wilson disease in Japan]. Rinsho shinkeigaku = Clinical neurology. 2019 Sep; 59(9):565-569. doi: 10.5692/clinicalneurol.cn-001241. [PMID: 31474637]
  • Chunyan Fu, Junhong Lizhao, Zhenghui Luo, Tao Wang, Craig A Grapperhaus, Xueqin Ding, Y James Kang. Active uptake of hydrophilic copper complex Cu(ii)-TETA in primary cultures of neonatal rat cardiomyocytes. Metallomics : integrated biometal science. 2019 03; 11(3):565-575. doi: 10.1039/c8mt00277k. [PMID: 30761393]
  • Jan Pfeiffenberger, Christine Marie Lohse, Daniel Gotthardt, Christian Rupp, Markus Weiler, Ulrike Teufel, Karl Heinz Weiss, Annika Gauss. Long-term evaluation of urinary copper excretion and non-caeruloplasmin associated copper in Wilson disease patients under medical treatment. Journal of inherited metabolic disease. 2019 03; 42(2):371-380. doi: 10.1002/jimd.12046. [PMID: 30746719]
  • Yoshinosuke Shimamura, Takuto Maeda, Yufu Gocho, Yayoi Ogawa, Kunihiko Tsuji, Hideki Takizawa. Immunoglobulin A nephropathy secondary to Wilson's disease: a case report and literature review. CEN case reports. 2019 02; 8(1):61-66. doi: 10.1007/s13730-018-0365-7. [PMID: 30255238]
  • Riikka Gunnar, Mirka Lumia, Mikko Pakarinen, Laura Merras-Salmio. Children With Intestinal Failure Undergoing Intestinal Rehabilitation Are at Risk for Essential Fatty Acid Deficiency. JPEN. Journal of parenteral and enteral nutrition. 2018 09; 42(7):1203-1210. doi: 10.1002/jpen.1152. [PMID: 29701873]
  • Jan Pfeiffenberger, Carlot Kruse, Peter Mutch, Andrew Harker, Karl Heinz Weiss. The steady state pharmacokinetics of trientine in Wilson disease patients. European journal of clinical pharmacology. 2018 Jun; 74(6):731-736. doi: 10.1007/s00228-018-2424-6. [PMID: 29417175]
  • Lianlian Wang, Xiaofang Luo, Cong Li, Yubing Huang, Ping Xu, Laetitia H Lloyd-Davies, Thibaut Delplancke, Chuan Peng, Rufei Gao, Hongbo Qi, Chao Tong, Philip Baker. Triethylenetetramine Synergizes with Pharmacologic Ascorbic Acid in Hydrogen Peroxide Mediated Selective Toxicity to Breast Cancer Cell. Oxidative medicine and cellular longevity. 2017; 2017(?):3481710. doi: 10.1155/2017/3481710. [PMID: 28280522]
  • Ji-Ming Yin, Li-Bo Sun, Jia-Sheng Zheng, Xin-Xin Wang, De-Xi Chen, Ning Li. Copper chelation by trientine dihydrochloride inhibits liver RFA-induced inflammatory responses in vivo. Inflammation research : official journal of the European Histamine Research Society ... [et al.]. 2016 Dec; 65(12):1009-1020. doi: 10.1007/s00011-016-0986-2. [PMID: 27613237]
  • Robin Tremmel, Philipp Uhl, Frieder Helm, Dominik Wupperfeld, Max Sauter, Walter Mier, Wolfgang Stremmel, Götz Hofhaus, Gert Fricker. Delivery of Copper-chelating Trientine (TETA) to the central nervous system by surface modified liposomes. International journal of pharmaceutics. 2016 Oct; 512(1):87-95. doi: 10.1016/j.ijpharm.2016.08.040. [PMID: 27553779]
  • Jennifer Nayor, Anand Vaidya, Amitabh Srivastava, Julian L Seifter, Anna E Rutherford. INTERACTIVE MEDICAL CASE. Tracing the Cause of Abdominal Pain. The New England journal of medicine. 2016 Aug; 375(6):e8. doi: 10.1056/nejmimc1512611. [PMID: 27509123]
  • Wen-Jie Li, Chen Chen, Zhi-Fei You, Ren-Min Yang, Xiao-Ping Wang. Current Drug Managements of Wilson's Disease: From West to East. Current neuropharmacology. 2016; 14(4):322-5. doi: 10.2174/1570159x14666151130222427. [PMID: 26639459]
  • Raoul Santiago, Frédéric Gottrand, Dominique Debray, Laure Bridoux, Alain Lachaux, Alain Morali, Delphine Lapeyre, Thierry Lamireau. Zinc Therapy for Wilson Disease in Children in French Pediatric Centers. Journal of pediatric gastroenterology and nutrition. 2015 Dec; 61(6):613-8. doi: 10.1097/mpg.0000000000000926. [PMID: 26230903]
  • Sebastian Brings, Shaoping Zhang, Yee S Choong, Sebastian Hogl, Martin Middleditch, Meder Kamalov, Margaret A Brimble, Deming Gong, Garth J S Cooper. Diabetes-induced alterations in tissue collagen and carboxymethyllysine in rat kidneys: Association with increased collagen-degrading proteinases and amelioration by Cu(II)-selective chelation. Biochimica et biophysica acta. 2015 Aug; 1852(8):1610-8. doi: 10.1016/j.bbadis.2015.04.014. [PMID: 25900786]
  • Aftab Ala, Ermal Aliu, Michael L Schilsky. Prospective pilot study of a single daily dosage of trientine for the treatment of Wilson disease. Digestive diseases and sciences. 2015 May; 60(5):1433-9. doi: 10.1007/s10620-014-3495-6. [PMID: 25605552]
  • Yang Cao, Marit Aralt Skaug, Ole Andersen, Jan Aaseth. Chelation therapy in intoxications with mercury, lead and copper. Journal of trace elements in medicine and biology : organ of the Society for Minerals and Trace Elements (GMS). 2015; 31(?):188-92. doi: 10.1016/j.jtemb.2014.04.010. [PMID: 24894443]
  • Nobuo Uehara, Yoshikuni Numanami, Toru Oba, Noriyuki Onishi, Xiaomao Xie. Thermal-induced Immuno-nephelometry Using Gold Nanoparticles Conjugated with a Thermoresponsive Polymer for the Detection of Avidin. Analytical sciences : the international journal of the Japan Society for Analytical Chemistry. 2015; 31(6):495-501. doi: 10.2116/analsci.31.495. [PMID: 26063011]
  • Dandan Jia, Lei Cao, Dongni Wang, Xuemin Guo, He Liang, Fangfang Zhao, Yaohang Gu, Dongjun Wang. Uncovering a broad class of fluorescent amine-containing compounds by heat treatment. Chemical communications (Cambridge, England). 2014 Oct; 50(78):11488-91. doi: 10.1039/c4cc05342g. [PMID: 25132137]
  • Jana Mattová, Pavla Poučková, Jan Kučka, Michaela Skodová, Miroslav Vetrík, Petr Stěpánek, Petr Urbánek, Miloš Petřík, Zbyněk Nový, Martin Hrubý. Chelating polymeric beads as potential therapeutics for Wilson's disease. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. 2014 Oct; 62(?):1-7. doi: 10.1016/j.ejps.2014.05.002. [PMID: 24815561]
  • Bui The Huy, Avvaru Praveen Kumar, Min-Ho Seo, Jan-Di Kim, Yong-Ill Lee. Controllable synthesis of thiol-capped CdTe nanoparticles for optical sensing of triethylenetetramine dihydrochloride. Journal of nanoscience and nanotechnology. 2014 Oct; 14(10):7662-7. doi: 10.1166/jnn.2014.9423. [PMID: 25942844]
  • Daniel P Hunt, Dushyant V Sahani, Kathleen E Corey, Ricard Masia. Case records of the Massachusetts General Hospital. Case 30-2014. A 29-year-old man with diarrhea, nausea, and weight loss. The New England journal of medicine. 2014 Sep; 371(13):1238-47. doi: 10.1056/nejmcpc1405218. [PMID: 25251619]
  • Ali Rezaei, Esfandiar Heidarian. Co-administration of trientine and flaxseed oil on oxidative stress, serum lipids and heart structure in diabetic rats. Indian journal of experimental biology. 2013 Aug; 51(8):646-52. doi: . [PMID: 24228388]
  • Z Mareček, R Brůha. [Wilsons disease]. Vnitrni lekarstvi. 2013 Jul; 59(7):578-83. doi: . [PMID: 23909262]
  • Valeria M Nurchi, Guido Crisponi, Miriam Crespo-Alonso, Joanna I Lachowicz, Zbigniew Szewczuk, Garth J S Cooper. Complex formation equilibria of Cu(II) and Zn(II) with triethylenetetramine and its mono- and di-acetyl metabolites. Dalton transactions (Cambridge, England : 2003). 2013 May; 42(17):6161-70. doi: 10.1039/c2dt32252h. [PMID: 23202417]
  • Venkata K Yellepeddi, Kiran K Vangara, Ajay Kumar, Srinath Palakurthi. Comparative evaluation of small-molecule chemosensitizers in reversal of cisplatin resistance in ovarian cancer cells. Anticancer research. 2012 Sep; 32(9):3651-8. doi: . [PMID: 22993302]
  • J M Walshe. Serum 'free' copper in Wilson disease. QJM : monthly journal of the Association of Physicians. 2012 May; 105(5):419-23. doi: 10.1093/qjmed/hcr229. [PMID: 22139498]
  • Marc Cerrada-Gimenez, Janne Weisell, Mervi T Hyvönen, Myung Hee Park, Leena Alhonen, Jouko Vepsäläinen, Tuomo A Keinänen. Complex N-acetylation of triethylenetetramine. Drug metabolism and disposition: the biological fate of chemicals. 2011 Dec; 39(12):2242-9. doi: 10.1124/dmd.111.041798. [PMID: 21878558]
  • Leire Moya-Olano, Helen Marie Milne, Jillian Margaret Robinson, Jonathan Vernon Hill, Christopher Miles Frampton, Helen Frances Abbott, Rufus Turner, Anthony James Kettle, Zoltán Huba Endre. Trientine and renin-angiotensin system blockade ameliorate progression of glomerular morphology in hypertensive experimental diabetic nephropathy. Pathology international. 2011 Nov; 61(11):652-61. doi: 10.1111/j.1440-1827.2011.02721.x. [PMID: 22029676]
  • Garth J S Cooper. Therapeutic potential of copper chelation with triethylenetetramine in managing diabetes mellitus and Alzheimer's disease. Drugs. 2011 Jul; 71(10):1281-320. doi: 10.2165/11591370-000000000-00000. [PMID: 21770477]
  • Jun Lu. Triethylenetetramine pharmacology and its clinical applications. Molecular cancer therapeutics. 2010 Sep; 9(9):2458-67. doi: 10.1158/1535-7163.mct-10-0523. [PMID: 20660601]
  • Scott C Miller, Xuli Wang, Beth M Bowman. Pharmacological properties of orally available, amphipathic polyaminocarboxylic acid chelators for actinide decorporation. Health physics. 2010 Sep; 99(3):408-12. doi: 10.1097/hp.0b013e3181bfb99b. [PMID: 20699705]
  • Zhiyuan Yu, Ren'an Wu, Minghuo Wu, Liang Zhao, Ruibin Li, Hanfa Zou. Preparation of polyamine-functionalized copper specific adsorbents for selective adsorption of copper. Colloids and surfaces. B, Biointerfaces. 2010 Jul; 78(2):222-8. doi: 10.1016/j.colsurfb.2010.03.004. [PMID: 20381321]
  • J Lu, D Gong, S Y Choong, H Xu, Y-K Chan, X Chen, S Fitzpatrick, S Glyn-Jones, S Zhang, T Nakamura, K Ruggiero, V Obolonkin, S D Poppitt, A R J Phillips, G J S Cooper. Copper(II)-selective chelation improves function and antioxidant defences in cardiovascular tissues of rats as a model of diabetes: comparisons between triethylenetetramine and three less copper-selective transition-metal-targeted treatments. Diabetologia. 2010 Jun; 53(6):1217-26. doi: 10.1007/s00125-010-1698-8. [PMID: 20221822]
  • Jun Lu, Sally D Poppitt, Asma A Othman, Tracey Sunderland, Katya Ruggiero, Michael S Willett, Lisa E Diamond, Wilfredo D Garcia, Benno G Roesch, Garth J S Cooper. Pharmacokinetics, pharmacodynamics, and metabolism of triethylenetetramine in healthy human participants: an open-label trial. Journal of clinical pharmacology. 2010 Jun; 50(6):647-58. doi: 10.1177/0091270009349379. [PMID: 20145262]
  • Tatiana G Levitskaia, Jeffrey A Creim, Terry L Curry, Teresa Luders, James E Morris, Angela D Woodstock, Barry Levinson, Karla D Thrall. Evaluation of Cuprimine and Syprine for decorporation of (60)Co and (210)Po. Health physics. 2010 Mar; 98(3):471-9. doi: 10.1097/hp.0b013e3181bcdf4f. [PMID: 20147789]
  • Deming Gong, Xiuyin Chen, Martin Middleditch, Liangdong Huang, Greeshma Vazhoor Amarsingh, Shiva Reddy, Jun Lu, Shaoping Zhang, Katya Ruggiero, Anthony R J Phillips, Garth J S Cooper. Quantitative proteomic profiling identifies new renal targets of copper(II)-selective chelation in the reversal of diabetic nephropathy in rats. Proteomics. 2009 Sep; 9(18):4309-20. doi: 10.1002/pmic.200900285. [PMID: 19634143]
  • George J Brewer, Fred Askari, Robert B Dick, Julia Sitterly, John K Fink, Martha Carlson, Karen J Kluin, Matthew T Lorincz. Treatment of Wilson's disease with tetrathiomolybdate: V. Control of free copper by tetrathiomolybdate and a comparison with trientine. Translational research : the journal of laboratory and clinical medicine. 2009 Aug; 154(2):70-7. doi: 10.1016/j.trsl.2009.05.002. [PMID: 19595438]
  • Hea-Young Cho, Robert A Blum, Tracey Sunderland, Garth J S Cooper, William J Jusko. Pharmacokinetic and pharmacodynamic modeling of a copper-selective chelator (TETA) in healthy adults. Journal of clinical pharmacology. 2009 Aug; 49(8):916-28. doi: 10.1177/0091270009337939. [PMID: 19602718]
  • Bo Lu, Chang-Fang Wang, De-Qun Wu, Cao Li, Xian-Zheng Zhang, Ren-Xi Zhuo. Chitosan based oligoamine polymers: synthesis, characterization, and gene delivery. Journal of controlled release : official journal of the Controlled Release Society. 2009 Jul; 137(1):54-62. doi: 10.1016/j.jconrel.2009.03.004. [PMID: 19303039]
  • D Gong, J Lu, X Chen, S Reddy, D J Crossman, S Glyn-Jones, Y-S Choong, J Kennedy, B Barry, S Zhang, Y-K Chan, K Ruggiero, A R J Phillips, G J S Cooper. A copper(II)-selective chelator ameliorates diabetes-evoked renal fibrosis and albuminuria, and suppresses pathogenic TGF-beta activation in the kidneys of rats used as a model of diabetes. Diabetologia. 2008 Sep; 51(9):1741-51. doi: 10.1007/s00125-008-1088-7. [PMID: 18636238]
  • Asma Othman, Jun Lu, Tracey Sunderland, Garth J S Cooper. Development and validation of a rapid HPLC method for the simultaneous determination of triethylenetetramine and its two main metabolites in human serum. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 Dec; 860(1):42-8. doi: 10.1016/j.jchromb.2007.10.006. [PMID: 17980682]
  • Jun Lu, Yi-Kai Chan, Sally D Poppitt, Garth J S Cooper. Determination of triethylenetetramine (TETA) and its metabolites in human plasma and urine by liquid chromatography-mass spectrometry (LC-MS). Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2007 Nov; 859(1):62-8. doi: 10.1016/j.jchromb.2007.09.001. [PMID: 17901001]
  • Masanobu Hayashi, Ryou Hirai, Yuusuke Ishihara, Noboru Horiguchi, Daiji Endoh, Toyo Okui. Combined effects of treatment with trientine, a copper-chelating agent, and x-irradiation on tumor growth in transplantation model of a murine fibrosarcoma. The Journal of veterinary medical science. 2007 Oct; 69(10):1039-45. doi: 10.1292/jvms.69.1039. [PMID: 17984591]
  • V Medici, L Rossaro, G C Sturniolo. Wilson disease--a practical approach to diagnosis, treatment and follow-up. Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver. 2007 Jul; 39(7):601-9. doi: 10.1016/j.dld.2006.12.095. [PMID: 17382611]
  • Ronen Arnon, Judith Flores Calderon, Michael Schilsky, Sukru Emre, Benjamin L Shneider. Wilson disease in children: serum aminotransferases and urinary copper on triethylene tetramine dihydrochloride (trientine) treatment. Journal of pediatric gastroenterology and nutrition. 2007 May; 44(5):596-602. doi: 10.1097/mpg.0b013e3180467715. [PMID: 17460493]
  • Aftab Ala, Ann P Walker, Keyoumars Ashkan, James S Dooley, Michael L Schilsky. Wilson's disease. Lancet (London, England). 2007 Feb; 369(9559):397-408. doi: 10.1016/s0140-6736(07)60196-2. [PMID: 17276780]
  • Jun Lu, Yi-Kai Chan, Gregory D Gamble, Sally D Poppitt, Asma A Othman, Garth J S Cooper. Triethylenetetramine and metabolites: levels in relation to copper and zinc excretion in urine of healthy volunteers and type 2 diabetic patients. Drug metabolism and disposition: the biological fate of chemicals. 2007 Feb; 35(2):221-7. doi: 10.1124/dmd.106.012922. [PMID: 17108057]
  • U Merle, M Schaefer, P Ferenci, W Stremmel. Clinical presentation, diagnosis and long-term outcome of Wilson's disease: a cohort study. Gut. 2007 Jan; 56(1):115-20. doi: 10.1136/gut.2005.087262. [PMID: 16709660]
  • Jeong Kee Seo. [Wilson disease: an update]. The Korean journal of hepatology. 2006 Sep; 12(3):333-63. doi: . [PMID: 16998287]
  • Masanobu Hayashi, Kazuhiro Miyane, Misato Senou, Daiji Endoh, Hidetoshi Higuchi, Hajime Nagahata, Kenji Nakayama, Yasuhiro Kon, Toyo Okui. Inhibitory effects of trientine, a copper-chelating agent, on induction of DNA strand breaks in kidney cells of Long-Evans Cinnamon (LEC) rats. Experimental animals. 2005 Oct; 54(5):403-12. doi: 10.1538/expanim.54.403. [PMID: 16365517]
  • Stefan U Christl, Dimitri Flieger, Ralf Keller, Wolfgang Stremmel, Wolfgang Fischbach. [Acute liver failure and hemolysis in a 16-year-old woman. First manifestation of Wilson's disease]. Medizinische Klinik (Munich, Germany : 1983). 2005 Sep; 100(9):579-82. doi: 10.1007/s00063-005-1063-8. [PMID: 16170647]
  • K H Chan, R T F Cheung, K M Au-Yeung, W Mak, T S Cheng, S L Ho. Wilson's disease with depression and parkinsonism. Journal of clinical neuroscience : official journal of the Neurosurgical Society of Australasia. 2005 Apr; 12(3):303-5. doi: 10.1016/j.jocn.2004.09.005. [PMID: 15851088]
  • George J Brewer. Neurologically presenting Wilson's disease: epidemiology, pathophysiology and treatment. CNS drugs. 2005; 19(3):185-92. doi: 10.2165/00023210-200519030-00001. [PMID: 15740174]
  • Garth J S Cooper, Anthony R J Phillips, Soon Y Choong, Bridget L Leonard, David J Crossman, Dianne H Brunton, 'Etuate L Saafi, Ajith M Dissanayake, Brett R Cowan, Alistair A Young, Christopher J Occleshaw, Yih-Kai Chan, Fiona E Leahy, Geraldine F Keogh, Gregory D Gamble, Grant R Allen, Adèle J Pope, Peter D W Boyd, Sally D Poppitt, Thomas K Borg, Robert N Doughty, John R Baker. Regeneration of the heart in diabetes by selective copper chelation. Diabetes. 2004 Sep; 53(9):2501-8. doi: 10.2337/diabetes.53.9.2501. [PMID: 15331567]
  • Hiroyuki Fukuda, Masaaki Ebara, Shinichiro Okabe, Masaharu Yoshikawa, Nobuyuki Sugiura, Hiromitsu Saisho, Fukuo Kondo, Masae Yukawa. Metal contents of liver parenchyma after percutaneous ethanol injection or radiofrequency ablation in patients with hepatocellular carcinoma before and after trientine hydrochloride therapy. The Journal of laboratory and clinical medicine. 2004 Jun; 143(6):333-9. doi: 10.1016/j.lab.2004.02.010. [PMID: 15192648]
  • Jiro Nakamura, Yoji Hamada, Sadao Chaya, Eitaro Nakashima, Keiko Naruse, Koichi Kato, Yutaka Yasuda, Hideki Kamiya, Fumihiko Sakakibara, Naoki Koh, Nigishi Hotta. Transition metals and polyol pathway in the development of diabetic neuropathy in rats. Diabetes/metabolism research and reviews. 2002 Sep; 18(5):395-402. doi: 10.1002/dmrr.319. [PMID: 12397582]
  • Yukitaka Nakano, Hitoshi Nohta, Hideyuki Yoshida, Tetsuya Saita, Hiroshi Fujito, Masato Mori, Masatoshi Yamaguchi. Liquid chromatographic determination of triethylenetetramine in human and rabbit sera based on intramolecular excimer-forming fluorescence derivatization. Journal of chromatography. B, Analytical technologies in the biomedical and life sciences. 2002 Jul; 774(2):165-72. doi: 10.1016/s1570-0232(02)00185-x. [PMID: 12076686]
  • M A Seguin, S E Bunch. Iatrogenic copper deficiency associated with long-term copper chelation for treatment of copper storage disease in a Bedlington Terrier. Journal of the American Veterinary Medical Association. 2001 May; 218(10):1593-7, 1580. doi: 10.2460/javma.2001.218.1593. [PMID: 11393371]
  • Y Shiono, H Hayashi, S Wakusawa, M Yano. Ultrastructural identification of iron and copper accumulation in the liver of a male patient with Wilson disease. Medical electron microscopy : official journal of the Clinical Electron Microscopy Society of Japan. 2001 Mar; 34(1):54-60. doi: 10.1007/s007950100004. [PMID: 11479773]
  • M Kobayashi, H Fujisaki, M Sugawara, K Iseki, K Miyazaki. Effects of interactions between drugs on the renal excretion of trientine in rats--acetazolamide and furosemide increase trientine excretion. Pharmaceutical research. 1999 Dec; 16(12):1888-92. doi: 10.1023/a:1018963712232. [PMID: 10644079]
  • K K Bhargava, Z Y Zhang, C J Palestro, S A Acharya. Synthesis of aminobenzyltriethylenetetraaminohexaacetic acid: conjugation of the chelator to protein by an alkylamine linkage. Journal of protein chemistry. 1999 Oct; 18(7):761-70. doi: 10.1023/a:1020629501426. [PMID: 10691186]
  • C Smolarek, W Stremmel. [Therapy of Wilson disease]. Zeitschrift fur Gastroenterologie. 1999 Apr; 37(4):293-300. doi: NULL. [PMID: 10378366]
  • M Kobayashi, H Fujisaki, M Sugawara, K Iseki, K Miyazaki. The presence of an Na+/spermine antiporter in the rat renal brush-border membrane. The Journal of pharmacy and pharmacology. 1999 Mar; 51(3):279-84. doi: 10.1211/0022357991772457. [PMID: 10344628]
  • T Yanagisawa, S Maemura, H Sasaki, T Endo, M Okada, P W East, D M Virgo, D M Creasy. Subacute and chronic toxicity studies of triethylenetetramine dihydrochloride (TJA-250) by oral administration to F-344 rats. The Journal of toxicological sciences. 1998 Oct; 23 Suppl 4(?):619-42. doi: 10.2131/jts.23.supplementiv_619. [PMID: 9836186]
  • H W Leung, T R Tyler. Pharmacokinetics and material balance studies of diethylenetriamine trihydrochloride in the Fischer 344 rat following oral, endotracheal or intravenous dosing. Journal of applied toxicology : JAT. 1997 Nov; 17(6):361-7. doi: 10.1002/(sici)1099-1263(199711/12)17:6<361::aid-jat453>3.0.co;2-u. [PMID: 9418943]
  • M Kobayashi, R Tanabe, M Sugawara, K Iseki, K Miyazaki. The mechanism of excretion of trientine from the rat kidney: trientine is not recognized by the H+/organic cation transporter. The Journal of pharmacy and pharmacology. 1997 Apr; 49(4):426-9. doi: 10.1111/j.2042-7158.1997.tb06818.x. [PMID: 9232542]
  • H Kodama, Y Murata, T Iitsuka, T Abe. Metabolism of administered triethylene tetramine dihydrochloride in humans. Life sciences. 1997; 61(9):899-907. doi: 10.1016/s0024-3205(97)00592-4. [PMID: 9284083]
  • M M Jones, C Xu, P K Singh, E M Walker. Cadmium mobilization by nitrogen donor chelating agents. Journal of toxicology and environmental health. 1996 May; 48(1):71-80. doi: 10.1080/009841096161474. [PMID: 8637059]
  • K Sone, M Maeda, K Wakabayashi, N Takeichi, M Mori, T Sugimura, M Nagao. Inhibition of hereditary hepatitis and liver tumor development in Long-Evans cinnamon rats by the copper-chelating agent trientine dihydrochloride. Hepatology (Baltimore, Md.). 1996 Apr; 23(4):764-70. doi: 10.1053/jhep.1996.v23.pm0008666330. [PMID: 8666330]
  • R Tanabe. [Disposition behavior and absorption mechanism of trientine, an orphan drug for Wilson's disease]. [Hokkaido igaku zasshi] The Hokkaido journal of medical science. 1996 Mar; 71(2):217-28. doi: NULL. [PMID: 8641677]
  • D L Greenman, R L Morrissey, W Blakemore, J Crowell, P Siitonen, P Felton, R Allen, G Cronin. Subchronic toxicity of triethylenetetramine dihydrochloride in B6C3F1 mice and F344 rats. Fundamental and applied toxicology : official journal of the Society of Toxicology. 1996 Feb; 29(2):185-93. doi: 10.1006/faat.1996.0020. [PMID: 8742314]
  • G J Brewer. Practical recommendations and new therapies for Wilson's disease. Drugs. 1995 Aug; 50(2):240-9. doi: 10.2165/00003495-199550020-00004. [PMID: 8521757]
  • M Arima. [Wilson's disease--evolutive panorama of diagnosis and treatment in the last forty years]. No to hattatsu = Brain and development. 1995 Mar; 27(2):96-103. doi: NULL. [PMID: 7727159]
  • C J Botha, T W Naude, G E Swan, J Dauth, M J Dreyer, M C Williams. The cupruretic effect of two chelators following copper loading in sheep. Veterinary and human toxicology. 1993 Oct; 35(5):409-13. doi: NULL. [PMID: 8249262]
  • M Suda, J Kubota, Y Yamaguchi, Y Fujioka, Y Saito, T Aoki. [A study of trientine therapy in Wilson's disease with neurological symptoms]. No to hattatsu = Brain and development. 1993 Sep; 25(5):429-34. doi: . [PMID: 8398232]
  • H Kodama, Y Meguro, A Tsunakawa, Y Nakazato, T Abe, H Murakita. Fate of orally administered triethylenetetramine dihydrochloride: a therapeutic drug for Wilson's disease. The Tohoku journal of experimental medicine. 1993 Jan; 169(1):59-66. doi: 10.1620/tjem.169.59. [PMID: 8211970]
  • H Tanaka, M Yamanouchi, S Imai, Y Hayashi. Low copper and brain abnormalities in fetus from triethylene tetramine dihydrochloride-treated pregnant mouse. Journal of nutritional science and vitaminology. 1992 Dec; 38(6):545-54. doi: 10.3177/jnsv.38.545. [PMID: 1304599]
  • J C Yarze, P Martin, S J Muñoz, L S Friedman. Wilson's disease: current status. The American journal of medicine. 1992 Jun; 92(6):643-54. doi: 10.1016/0002-9343(92)90783-8. [PMID: 1605146]
  • K Iseki, M Kobayashi, A Ohba, K Miyazaki, Y Li, Y Togashi, N Takeichi. Comparison of disposition behavior and de-coppering effect of triethylenetetramine in animal model for Wilson's disease (Long-Evans Cinnamon rat) with normal Wistar rat. Biopharmaceutics & drug disposition. 1992 May; 13(4):273-83. doi: 10.1002/bdd.2510130406. [PMID: 1600113]
  • D G Brodland, G B Bartley. Kayser-Fleischer rings in a patient with basal cell carcinoma: fortuitous diagnosis of presymptomatic Wilson's disease. Mayo Clinic proceedings. 1992 Feb; 67(2):142-3. doi: 10.1016/s0025-6196(12)61315-9. [PMID: 1545578]
  • J Morita, M Yoshino, H Watari, I Yoshida, T Motohiro, F Yamashita, Y Okano, T Hashimoto. Wilson's disease treatment by triethylene tetramine dihydrochloride (trientine, 2HCl): long-term observations. Developmental pharmacology and therapeutics. 1992; 19(1):6-9. doi: 10.1159/000457456. [PMID: 1307347]
  • R Siegemund, J Lössner, K Günther, H J Kühn, H Bachmann. Mode of action of triethylenetetramine dihydrochloride on copper metabolism in Wilson's disease. Acta neurologica Scandinavica. 1991 Jun; 83(6):364-6. doi: 10.1111/j.1600-0404.1991.tb03964.x. [PMID: 1887758]
  • H Saito, K Watanabe, M Sahara, R Mochizuki, K Edo, Y Ohyama. Triethylene-tetramine (trien) therapy for Wilson's disease. The Tohoku journal of experimental medicine. 1991 May; 164(1):29-35. doi: 10.1620/tjem.164.29. [PMID: 1926144]
  • M L Schilsky, I H Scheinberg, I Sternlieb. Prognosis of Wilsonian chronic active hepatitis. Gastroenterology. 1991 Mar; 100(3):762-7. doi: 10.1016/0016-5085(91)80023-3. [PMID: 1993498]
  • M Kobayashi, M Sugawara, H Saitoh, K Iseki, K Miyazaki. [Intestinal absorption and urinary excretion of triethylenetetramine for Wilson's disease in rat]. Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan. 1990 Oct; 110(10):759-63. doi: 10.1248/yakushi1947.110.10_759. [PMID: 2074531]
  • K Miyazaki, S Kishino, M Kobayashi, S Arashima, S Matsumoto, T Arita. Determination of triethylenetetramine in plasma of patients by high-performance liquid chromatography. Chemical & pharmaceutical bulletin. 1990 Apr; 38(4):1035-8. doi: 10.1248/cpb.38.1035. [PMID: 2379276]
  • V Eybl, M Koutenská, J Koutenský, J Sýkora, V Smolíková. Influence of triethylenetetramine and D-penicillamine on zinc metabolism in mice. Archives of toxicology. Supplement. = Archiv fur Toxikologie. Supplement. 1989; 13(?):370-2. doi: 10.1007/978-3-642-74117-3_72. [PMID: 2774962]
  • M S Rao, R S Dwivedi, V Subbarao, M I Usman, D G Scarpelli, M R Nemali, A Yeldandi, S Thangada, S Kumar, J K Reddy. Almost total conversion of pancreas to liver in the adult rat: a reliable model to study transdifferentiation. Biochemical and biophysical research communications. 1988 Oct; 156(1):131-6. doi: 10.1016/s0006-291x(88)80814-3. [PMID: 3178826]
  • D C Twedt, H A Hunsaker, K G Allen. Use of 2,3,2-tetramine as a hepatic copper chelating agent for treatment of copper hepatotoxicosis in Bedlington terriers. Journal of the American Veterinary Medical Association. 1988 Jan; 192(1):52-6. doi: NULL. [PMID: 3343179]
  • M Athar, M Misra, R C Srivastava. Evaluation of chelating drugs on the toxicity, excretion, and distribution of nickel in poisoned rats. Fundamental and applied toxicology : official journal of the Society of Toxicology. 1987 Jul; 9(1):26-33. doi: 10.1016/0272-0590(87)90150-3. [PMID: 3622960]
  • E Yano. Increased activity of monoamine oxidase by epoxy resin hardeners. Toxicology letters. 1987 Jun; 37(1):27-32. doi: 10.1016/0378-4274(87)90163-9. [PMID: 3590227]